[Use of the preparation Iso Mack Retard 60 mg I 120 mg in the treatment of patients with advanced ischemic heart disease].
The purpose of the study was an evaluation of the effectiveness of the preparation ISO MACK RETARD in capsules of 60 mg and 120 mg in patients with advanced exacerbated ischaemic heart disease. The study included 72 patients, in 61 (84.7%) of them very good result treatment, estimated subjectively, was achieved. ISO MACK RETARD in capsules of 60 and 120 mg was well tolerated; in the studied group no side effects were observed.